ETFChannel.com
BIIB Description — Biogen Inc

Biogen is a biopharmaceutical company focused on discovering, developing and delivering therapies for people living with neurological and neurodegenerative diseases as well as related therapeutic adjacencies. Co.'s main growth areas include multiple sclerosis (MS) and neuroimmunology; Alzheimer's disease and dementia; neuromuscular disorders, including spinal muscular atrophy (SMA) and amyotrophic lateral sclerosis; movement disorders, including Parkinson's disease; and ophthalmology. Co.'s marketed products include TECFIDERA, AVONEX, PLEGRIDY, TYSABRI, VUMERITY and FAMPYRA for the treatment of MS, SPINRAZA for the treatment of SMA and FUMADERM for the treatment of severe plaque psoriasis.

Company Name: 
Biogen Inc
Website: 
www.biogen.com
Sector: 
Biotechnology
Number of ETFs Holding BIIB: 
117
Total Market Value Held by ETFs: 
$7,053,244,934.56
Total Market Capitalization: 
$48,282,000,000
% of Market Cap. Held by ETFs: 
14.61%
 ETF   BIIB Weight   BIIB Amount 
 VTI   0.18%   $1,583,687,886         
 VOO   0.21%   $1,111,456,835         
 QQQ   0.54%   $593,473,290         
 SPY   0.21%   $574,971,163         
 IBB   5.61%   $482,938,508         
 IVV   0.21%   $402,694,682         
 XLV   1.44%   $375,936,663         
 VTV   0.45%   $363,535,167         
 VHT   1.22%   $140,937,976         
 QUAL   0.75%   $135,514,660         
List of all 117 ETFs holding BIIB »
Quotes delayed 20 minutes

Hold (2.40 out of 4)
15th percentile
(ranked lower than approx. 85% of all stocks covered)

Analysts Forecast:
BIIB Price Target

Based on data provided by Zacks Investment Research via Quandl.com

ETFs Holding BIIB | Biogen Inc | ETF Channel | www.ETFChannel.com

Copyright © 2010 - 2020, All Rights Reserved Nothing in ETF Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and ETF videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact ETF Channel; Meet Our Editorial Staff.